Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies

This is a registry study collecting tumor samples from patients with blood cancers — such as leukemia, lymphoma, or myeloma — to study how cancer cells respond to different drugs in a lab setting. This approach, called drug response profiling (DRP), aims to help doctors predict which treatments will be most effective for individual patients. **You may be eligible if...** - You are under 40 years old - You have been diagnosed with a blood cancer (leukemia, lymphoma, or myeloma) — whether newly diagnosed, relapsed, or treatment-resistant - Tumor material has been collected as part of your routine care and you are willing to donate it for research - You or your guardian have signed a consent form for either this registry or a clinical trial that includes DRP research **You may NOT be eligible if...** - You have not signed the required informed consent - You are 40 years of age or older Talk to your doctor to see if this trial is right for you.